Treatment of lyme disease

JAMA - Journal of the American Medical Association

Volumn 315, Issue 22, 2016, Pages 2461-2462

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFTRIAXONE; CEFUROXIME AXETIL; DOXYCYCLINE; INSECT REPELLENT;

ANTIBIOTIC PROPHYLAXIS; ARTHRITIS; BORRELIA; BORRELIA BURGDORFERI; BORRELIA MAYONII; CLINICAL FEATURE; COGNITIVE DEFECT; CRANIAL NERVE PARALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; DRUG CONTRAINDICATION; ERYTHEMA CHRONICUM MIGRANS; FACIAL NERVE PARALYSIS; FATIGUE; FIRST DEGREE ATRIOVENTRICULAR BLOCK; HUMAN; IXODES SCAPULARIS; LYME DISEASE; MENINGITIS; MUSCULOSKELETAL PAIN; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RADICULOPATHY; SHORT SURVEY; SYMPTOM; TICK BITE;

EID: 84974802718     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.6888     Document Type: Short Survey

References (9)

1. Sanchez E, Vannier E, Wormser GP, Hu LT. Diagnosis, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: a review. JAMA. 2016;315(16):1767-1777.
2. Pritt BS, Mead PS, Johnson DK, et al. Identification of a novel pathogenic Borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: a descriptive study [published online February 5, 2016]. Lancet Infect Dis. doi:10.1016/S1473-3099(15)00464-8.
3. Wilhelmsson P, Lindgren PE. Detection of a novel Lyme borreliosis pathogen [published online February 5, 2016]. Lancet Infect Dis. doi:10.1016/S1473-3099(15)00483-1.
4. Insect repellents. Med Lett Drugs Ther. 2012;54 (1399):75-76.
5. Warshafsky S, Lee DH, Francois LK, Nowakowski J, Nadelman RB, Wormser GP. Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis. J Antimicrob Chemother. 2010;65(6):1137-1144.
6. Lantos PM, Charini WA, Medoff G, et al. Final report of the Lyme disease review panel of the Infectious Diseases Society of America. Clin Infect Dis. 2010;51(1):1-5.
7. Weitzner E, McKenna D, Nowakowski J, et al. Long-term assessment of post-treatment symptoms in patients with culture-confirmed early Lyme disease. Clin Infect Dis. 2015;61(12):1800-1806.
8. Berende A, ter Hofstede HJ, Vos FJ, et al. Randomized trial of longer-term therapy for symptoms attributed to Lyme disease. N Engl J Med. 2016;374(13):1209-1220.
9. Nadelman RB, Hanincová K, Mukherjee P, et al. Differentiation of reinfection from relapse in recurrent Lyme disease. N Engl J Med. 2012;367 (20):1883-1890.